Intranasal ketamine for procedural sedation in children: An open-label multicenter clinical trial

Soha Rached-d'Astous1, Yaron Finkelstein2, Benoit Bailey1

  • 1Pediatric Emergency Department, Centre Hospitalier Universitaire Sainte Justine, Université de Montréal, 3175 Chem. de la Cote-Sainte-Catherine, Montreal, Quebec H3T 1C5, Canada.

Insights

Intranasal ketamine at 6 mg/kg effectively sedated 60% of children for laceration repair, offering a needle-free option for procedural pain management. This study highlights its potential as a safe and viable alternative for pediatric emergency care.

Area of Science:

  • Pediatric Emergency Medicine
  • Pain Management
  • Pharmacology

Background:

  • Effective procedural sedation in children for minor injuries like lacerations is challenging without IV access.
  • Intranasal ketamine offers a needle-free alternative for pediatric procedural sedation.
  • A prior dose-escalation study identified 6 mg/kg as a potentially optimal dose.

Purpose of the Study:

  • To evaluate the efficacy and safety of 6 mg/kg intranasal ketamine for sedating children undergoing laceration repair with sutures.
  • To determine the success rate of procedural sedation using this non-intravenous method.

Main Methods:

  • A single-arm, open-label, multicenter clinical trial was conducted.
  • 30 children aged 1-12 years received 6 mg/kg intranasal ketamine for laceration repair.
  • The primary outcome measured was the proportion of patients achieving effective procedural sedation.

Main Results:

  • Sedation was effective in 60% (18/30) of children.
  • An additional 17% (5/30) experienced suboptimal sedation but completed the procedure with minimal difficulty.
  • No serious adverse events were reported during the study.

Conclusions:

  • A single 6 mg/kg dose of intranasal ketamine achieved successful procedural sedation in 60% of pediatric patients undergoing laceration repair.
  • The treatment was generally safe and facilitated procedure completion, even in cases of suboptimal sedation.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
179
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
413
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
475